BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ho YL, Joelsons D, Leite GFC, Malbouisson LMS, Song ATW, Perondi B, Andrade LC, Pinto LF, D'Albuquerque LAC, Segurado AAC; Hospital das Clínicas Yellow Fever Assistance Group. Severe yellow fever in Brazil: clinical characteristics and management. J Travel Med 2019;26:taz040. [PMID: 31150098 DOI: 10.1093/jtm/taz040] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 16.0] [Reference Citation Analysis]
Number Citing Articles
1 Raadsen M, Du Toit J, Langerak T, van Bussel B, van Gorp E, Goeijenbier M. Thrombocytopenia in Virus Infections. J Clin Med 2021;10:877. [PMID: 33672766 DOI: 10.3390/jcm10040877] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
2 Leong WY. COVID-19's impact on travel medicine surpasses that of all other emerging viral diseases. J Travel Med 2020;27:taaa221. [PMID: 33247591 DOI: 10.1093/jtm/taaa221] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Neves YCS, Castro-Lima VAC, Solla DJF, Ogata VSM, Pereira FL, Araujo JM, Ho YL, Chammas MC. Ultrasound Findings and Laboratory Predictors of Early Mortality in Patients With Severe Yellow Fever. AJR Am J Roentgenol 2021;216:1392-9. [PMID: 33703928 DOI: 10.2214/AJR.20.23455] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Lecomte E, Laureys G, Verbeke F, Domingo Carrasco C, Van Esbroeck M, Huits R. A clinician's perspective on yellow fever vaccine-associated neurotropic disease. J Travel Med 2020;27:taaa172. [PMID: 32965473 DOI: 10.1093/jtm/taaa172] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
5 Osman S, Preet R. Dengue, chikungunya and Zika in GeoSentinel surveillance of international travellers: a literature review from 1995 to 2020. J Travel Med 2020;27:taaa222. [PMID: 33258476 DOI: 10.1093/jtm/taaa222] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
6 Staples JE, Barrett ADT, Wilder-Smith A, Hombach J. Review of data and knowledge gaps regarding yellow fever vaccine-induced immunity and duration of protection. NPJ Vaccines 2020;5:54. [PMID: 32655896 DOI: 10.1038/s41541-020-0205-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
7 Cunha MS, Faria NR, Caleiro GS, Candido DS, Hill SC, Claro IM, da Costa AC, Nogueira JS, Maeda AY, da Silva FG, de Souza RP, Spinola R, Tubaki RM, de Menezes RMT, Abade L, Mucci LF, Timenetsky MDCST, Sabino E. Genomic evidence of yellow fever virus in Aedes scapularis, southeastern Brazil, 2016. Acta Trop 2020;205:105390. [PMID: 32044285 DOI: 10.1016/j.actatropica.2020.105390] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
8 de Oliveira Figueiredo P, Stoffella-Dutra AG, Barbosa Costa G, Silva de Oliveira J, Dourado Amaral C, Duarte Santos J, Soares Rocha KL, Araújo Júnior JP, Lacerda Nogueira M, Zazá Borges MA, Pereira Paglia A, Desiree LaBeaud A, Santos Abrahão J, Geessien Kroon E, Bretas de Oliveira D, Paiva Drumond B, de Souza Trindade G. Re-Emergence of Yellow Fever in Brazil during 2016-2019: Challenges, Lessons Learned, and Perspectives. Viruses 2020;12:E1233. [PMID: 33143114 DOI: 10.3390/v12111233] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
9 Wilder-Smith A. COVID-19 in comparison with other emerging viral diseases: risk of geographic spread via travel. Trop Dis Travel Med Vaccines 2021;7:3. [PMID: 33517914 DOI: 10.1186/s40794-020-00129-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Wilder-Smith A. End of year editorial: hot topics in travel medicine. J Travel Med 2020;27:taaa215. [PMID: 33225360 DOI: 10.1093/jtm/taaa215] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
11 Koehl B, Aupiais C, Schinckel N, Mornand P, Odièvre MH, Niakate A, Brousse V, Ithier G, Missud F, Holvoet L, Benkerrou M, Sorge F, Faye A. Tolerance and humoral immune response to the yellow fever vaccine in sickle cell disease children treated with hydroxyurea: a multicentre prospective study. J Travel Med 2021;28:taab013. [PMID: 33550421 DOI: 10.1093/jtm/taab013] [Reference Citation Analysis]
12 Kallas EG, Wilder-Smith A. Managing severe yellow fever in the intensive care: lessons learnt from Brazil. J Travel Med 2019;26:taz043. [PMID: 31180486 DOI: 10.1093/jtm/taz043] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
13 McEntire CRS, Song KW, McInnis RP, Rhee JY, Young M, Williams E, Wibecan LL, Nolan N, Nagy AM, Gluckstein J, Mukerji SS, Mateen FJ. Neurologic Manifestations of the World Health Organization's List of Pandemic and Epidemic Diseases. Front Neurol 2021;12:634827. [PMID: 33692745 DOI: 10.3389/fneur.2021.634827] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Hall C, Khodr ZG, Chang RN, Bukowinski AT, Gumbs GR, Conlin AMS. Safety of yellow fever vaccination in pregnancy: findings from a cohort of active duty US military women. J Travel Med 2020;27:taaa138. [PMID: 32830852 DOI: 10.1093/jtm/taaa138] [Reference Citation Analysis]
15 Liu Y, Rocklöv J. What is the reproductive number of yellow fever? J Travel Med 2020;27:taaa156. [PMID: 32889541 DOI: 10.1093/jtm/taaa156] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
16 Gehrke F, Cardoso Gois K, da Costa Alves Aguiar Reis B, Zorello Laporta G, Affonso Fonseca FL. Dengue 2 serotype and yellow fever coinfection. Access Microbiol 2021;3:000300. [PMID: 35024560 DOI: 10.1099/acmi.0.000300] [Reference Citation Analysis]
17 Bifani AM, Ong EZ, de Alwis R. Vaccination and Therapeutics: Responding to the Changing Epidemiology of Yellow Fever. Curr Treat Options Infect Dis 2020;:1-12. [PMID: 32837338 DOI: 10.1007/s40506-020-00232-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Song ATW, Clemente WT. Yellow Fever in Transplantation. Curr Infect Dis Rep 2021;23. [DOI: 10.1007/s11908-021-00761-2] [Reference Citation Analysis]
19 Bailey AL, Kang LI, de Assis Barros D'Elia Zanella LGF, Silveira CGT, Ho YL, Foquet L, Bial G, McCune BT, Duarte-Neto AN, Thomas A, Raué HP, Byrnes K, Kallas EG, Slifka MK, Diamond MS. Consumptive coagulopathy of severe yellow fever occurs independently of hepatocellular tropism and massive hepatic injury. Proc Natl Acad Sci U S A 2020;117:32648-56. [PMID: 33268494 DOI: 10.1073/pnas.2014096117] [Reference Citation Analysis]
20 Neves YCS, Castro-Lima VAC, Solla DJF, Ogata VSM, Pereira FL, Araujo JM, Nastri ACS, Ho YL, Chammas MC. Staging liver fibrosis after severe yellow fever with ultrasound elastography in Brazil: A six-month follow-up study. PLoS Negl Trop Dis 2021;15:e0009594. [PMID: 34283826 DOI: 10.1371/journal.pntd.0009594] [Reference Citation Analysis]
21 Silva NIO, Sacchetto L, de Rezende IM, Trindade GS, LaBeaud AD, de Thoisy B, Drumond BP. Recent sylvatic yellow fever virus transmission in Brazil: the news from an old disease. Virol J 2020;17:9. [PMID: 31973727 DOI: 10.1186/s12985-019-1277-7] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 15.5] [Reference Citation Analysis]
22 Wilder-Smith A, Osman S. Public health emergencies of international concern: a historic overview. J Travel Med 2020;27:taaa227. [PMID: 33284964 DOI: 10.1093/jtm/taaa227] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]
23 Lataillade LG, Vazeille M, Obadia T, Madec Y, Mousson L, Kamgang B, Chen CH, Failloux AB, Yen PS. Risk of yellow fever virus transmission in the Asia-Pacific region. Nat Commun 2020;11:5801. [PMID: 33199712 DOI: 10.1038/s41467-020-19625-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
24 Wilder-smith A. Yellow Fever in Travelers. Curr Infect Dis Rep 2019;21. [DOI: 10.1007/s11908-019-0701-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
25 Bühler S, Jaeger VK, Eperon G, Furrer H, Fux CA, Jansen S, Neumayr A, Rochat L, Schmid S, Schmidt-Chanasit J, Staehelin C, de Visser AW, Visser LG, Niedrig M, Hatz C. Safety and immunogenicity of a primary yellow fever vaccination under low-dose methotrexate therapy-a prospective multi-centre pilot study1. J Travel Med 2020;27:taaa126. [PMID: 32729905 DOI: 10.1093/jtm/taaa126] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
26 Reno E, Quan NG, Franco-Paredes C, Chastain DB, Chauhan L, Rodriguez-Morales AJ, Henao-Martínez AF. Prevention of yellow fever in travellers: an update. Lancet Infect Dis 2020;20:e129-37. [PMID: 32386609 DOI: 10.1016/S1473-3099(20)30170-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
27 Tomashek KM, Challberg M, Nayak SU, Schiltz HF. Disease Resurgence, Production Capability Issues and Safety Concerns in the Context of an Aging Population: Is There a Need for a New Yellow Fever Vaccine? Vaccines (Basel) 2019;7:E179. [PMID: 31717289 DOI: 10.3390/vaccines7040179] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
28 Bifani AM, Ong EZ, de Alwis R. Vaccination and Therapeutics: Responding to the Changing Epidemiology of Yellow Fever. Curr Treat Options Infect Dis 2020;:1-12. [PMID: 33173445 DOI: 10.1007/s40506-020-00237-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Cracknell Daniels B, Gaythorpe K, Imai N, Dorigatti I. Yellow fever in Asia-a risk analysis. J Travel Med 2021;28:taab015. [PMID: 33506250 DOI: 10.1093/jtm/taab015] [Reference Citation Analysis]
30 Servadio JL, Muñoz-Zanzi C, Convertino M. Estimating case fatality risk of severe Yellow Fever cases: systematic literature review and meta-analysis. BMC Infect Dis 2021;21:819. [PMID: 34399718 DOI: 10.1186/s12879-021-06535-4] [Reference Citation Analysis]